#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus associated lymphoproliferative disorder Ataxia telangiectasia Acute hepatic failure IPEX syndrome Gastrointestinal stromal tumour Haemophilia A with anti factor VIII Glomerulonephritis membranoproliferative Nephrotic syndrome Kearns-Sayre syndrome Extra-osseous Ewing's sarcoma recurrent Heritable pulmonary arterial hypertension Adenocarcinoma gastric Homocystinuria PIK3CA-activated mutation Lymphangioma More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Treatment KBG syndrome – Basic Information Glycogen storage disease type II – Diagnostics Waldenstrom’s macroglobulinaemia refractory Alternating hemiplegia of childhood – Diagnostics Chordoma – Diagnostics Inclusion body myositis – Diagnostics Haemophilia A without inhibitors – Life with Disease Kearns-Sayre syndrome – Diagnostics Antisynthetase syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rp-1664 Sulfate LVT-001 VENT-03 Taldefgrobep Alfa Posdinemab Ecoo4 Ganaxolone Zofenopril Calcium Lovastatin ETX-19477 Microcrystalline Cellulose Iopamidol Mirvetuximab Soravtansine Osilodrostat CANNABINOL Piritramide Syn2 Remestemcel Methylone L-Arginine Hydrochloride More therapies…

    Learn about Your Condition

    Graft infection Heart disease congenital Pyelonephritis Scoliosis Depression Head injury Blood iron increased Tissue anoxia Head and neck cancer stage IV Psoriasis Hypopituitarism Small intestine leiomyosarcoma Herpes virus infection Stargardt's disease Pterygium More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • HLX43
    France Italy Poland Romania Spain

  • A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

    Recruiting

    3 1
    Investigated Drugs:
    • L-Acetylleucine
    Austria Germany Greece Italy

  • Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

    Recruiting

    3 1
    Investigated Drugs:
    • Dactylis Glomerata Pollen Extract
    • Festuca Elatior Pollen Extract
    • Lolium Perenne Pollen Extract
    Portugal Spain

  • Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis
    • Conjunctivitis allergic
    Investigated Drugs:
    • Dactylis Glomerata Pollen Extract
    • Festuca Elatior Pollen Extract
    • Lolium Perenne Pollen Extract
    Portugal Spain

  • A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

    Recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Levosimendan
    Austria Bulgaria Czechia France Germany Hungary +3

  • Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

    Recruiting

    2 1 1
    Investigated Diseases:
    • CADASIL
    • Dementia
    • Prodromal Alzheimer’s disease
    Investigated Drugs:
    • [18F]DED
    Spain
Previous Page
1 … 38 39 40 41 42 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!